D57.219
Sickle-cell/Hb-C disease with crisis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Sickle-cell/Hb-C disease with crisis NOS
- Sickle-cell/Hb-C disease with (vaso-occlusive) pain NOS
Medical Intelligence & Overview
Sickle-cell/Hb-C disease with crisis, unspecified (ICD-10 code D57.219), refers to a form of inherited blood disorder characterized by abnormal hemoglobin. This condition involves episodes of severe pain and other health complications due to the sickling of red blood cells. The term 'with crisis' indicates that the patient is experiencing or has experienced an acute episode, often involving vaso-occlusive pain. Understanding this condition can help patients and caregivers recognize symptoms and manage health effectively under medical guidance.
Causes & Symptoms
Clinical Causes: Inherited genetic mutation affecting hemoglobin production Presence of abnormal hemoglobin called hemoglobin S or Hemoglobin C Carrying two copies of the sickle gene (sickle cell anemia) or one copy of the sickle gene and one of the C gene (hemoglobin C disease)
Key Symptoms: Severe episodes of pain, often called sickle cell crises Swelling in hands and feet Itching Frequent infections Delayed growth or puberty in children Vision problems caused by blocked blood vessels in the eye Fatigue and weakness due to anemia Jaundice or yellowing of the skin and eyes
Diagnostic & Treatment
Diagnosis Path: The diagnosis is typically confirmed through blood tests, including hemoglobin electrophoresis, which identifies abnormal hemoglobin types. A complete blood count (CBC) can reveal anemia, and additional tests may assess organ function or detect complications. Medical professionals evaluate the patient's medical history and symptoms to establish the diagnosis and determine the severity of the disease.
Treatment Protocols: Pain management during crises using medications such as analgesics Hydration therapy to help reduce the sickling of cells Blood transfusions to dilute sickled cells and reduce symptoms Use of hydroxyurea to decrease crisis frequency and improve blood flow Infection prevention through vaccinations and antibiotics Regular health monitoring for organ damage or other complications Supportive care including folic acid supplementation and nutritional support
Clinical Advice & FAQs
Billing Guidance
Is D57.219 a billable ICD-10 code?
Yes, D57.219 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.219?
Clinical documentation must specify the nature of Sickle-cell/Hb-C disease with crisis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference